Microcatheters and advance imaging
The PET-MR system will prove to be a boon in restricting the brain surgeries up to minimally invasive as well as handle complex neurological disorders. Dr (Prof ) P N Renjen Sr Consultant - Neurologist (Stroke), Department of Neurosciences, Indraprastha Apollo Hospitals embolic agents and flow diversion device) and support devices (microcatheter, and microguidewire),” informs Dr Renjen.
Advance imaging and prospects In neurology, PET SUITE is the most advanced imaging technology available in India at Indraprastha Apollo Hospitals after CT and MR technologies. This device integrates PET-MR and PET-CT, that allows technicians to acquire precise data on functions, morphology and metabolism. Unprecedented technological development around the world is allowing humans to cross the unlimited boundaries and enter into and era of advanced medical imaging. Most up-to-date advancements and breakthroughs in medical imaging technology have transformed the way patient care is delivered in the new age. Apart from its application in cancer, PET-MR also plays a greater role in understanding various disorders progression in cardiology and neurological diseases. Its ‘zero’ radiation exposure from the machine (unlike CT), makes it safe for paediatric case evaluation, reproductive age group women and can be used for disease follow up. PET-MR establishes a new understanding of the previously unknown interrelation between different measures of pathology and physiology in human body. With enhanced ability to explore correlations between structure and function, perfusion and metabolism, tissue diffusivity and cell proliferation, PET-MR potentiates doctor’s ability of gaining new insight into the progress of disease, unlocking new paths to treatment or even opening new areas of research. The PET-MR system will prove to be a boon in restricting the brain surgeries up to minimally invasive as well as handle complex neurological disorders, which are more evident with the changing lifestyle. “Growing ageing and obese population, rising patient pool for ischemic and haemorrhagic stroke and increasing demand for minimally invasive surgical procedures. Upcoming clinical trial data is favouring the interventional procedure over neurosurgery as it offers limited hospital stays, minimal damage to surrounding healthy tissues, lesser chances of infection in post-surgical phase, minimum surgical trauma and lesser surgical scar,” Dr Renjen avers. (nikunj.kumar@network18publishing.com)
June 2013 I
47